Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Keith Wheatley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk Neuroblastoma
Gains, J. E., Patel, A., Chang, Y.-C., Mandeville, H. C., Smyth, G., Stacey, C., Talbot, J., Wheatley, K. & Gaze, M. N., 15 Mar 2024, (E-pub ahead of print) In: Clinical Oncology.Research output: Contribution to journal › Article › peer-review
-
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
Innovative Therapies for Children with Cancer (ITCC) Consortium & European Association for Neuroblastoma Research (SIOPEN), 8 Jan 2024, (E-pub ahead of print) In: Journal of Clinical Oncology.Research output: Contribution to journal › Article › peer-review
Open AccessFile55 Downloads (Pure) -
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998
Chisholm, J., Mandeville, H., Adams, M., Minard-Collin, V., Rogers, T., Kelsey, A., Shipley, J., van Rijn, R. R., de Vries, I., van Ewijk, R., de Keizer, B., Gatz, S. A., Casanova, M., Hjalgrim, L. L., Firth, C., Wheatley, K., Kearns, P., Liu, W., Kirkham, A. & Rees, H. & 7 others, , 9 Oct 2024, In: Cancers. 16, 19, 2 p., 3427.Research output: Contribution to journal › Comment/debate › peer-review
Open AccessFile39 Downloads (Pure) -
Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374
Bailey, S., André, N., Gandola, L., Massimino, M., Wheatley, K., Gates, S., Homer, V., Rutkowski, S. & Clifford, S. C., 7 Mar 2024, In: Cancers. 16, 6, 2 p., 1084.Research output: Contribution to journal › Comment/debate
Open AccessFile87 Downloads (Pure) -
Correction to: The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review
Wilson, J. S., Main, C., Thorp, N., Taylor, R. E., Majothi, S., Kearns, P. R., English, M., Dandapani, M., Phillips, R., Wheatley, K. & Pizer, B., 5 Mar 2024, (E-pub ahead of print) In: Journal of Neuro-Oncology.Research output: Contribution to journal › Comment/debate › peer-review
Open AccessFile75 Downloads (Pure)
-
STELLAR: A Phase 2, Randomised Study of CHOP-R in Combination with acalabrutinib followed by acalabrutinib maintenance compared to CHOP-R followed by acalabrutinib at disease progression for patients...
Craddock, C. (Principal Investigator), Jackson, A. (Co-Investigator), Boucher, B. (Researcher), Siddique, S. (Co-Investigator) & Wheatley, K. (Co-Investigator)
7/12/18 → 6/06/26
Project: Research
-
MITHRIDATE, A Multicenter International sTudy comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera
Oppong, R. (Co-Investigator), Gaunt, C. (Co-Investigator), Wheatley, K. (Co-Investigator) & Jackson, A. (Principal Investigator)
GUYS & ST THOMAS CHARITY, NOVARTIS PHARMA A.G.
21/09/18 → 20/09/29
Project: Research
-
CRUK/14/013: An international randomised phase III clinical trial in children with acute myeloid leukaemia (MyeChild01)
Kearns, P. (Co-Investigator), Jackson, A. (Principal Investigator) & Wheatley, K. (Co-Investigator)
Pfizer Inc, Cancer Research Uk, GALEN LTD
1/10/14 → 30/06/33
Project: Research
-
ENDED. OPEN ONLY FOR ARCHIVING AND PUBLISHING COST.Systematic Reviews in Childrens Cancer: CNS Tumours
Wilson, J. (Principal Investigator), Kearns, P. (Co-Investigator) & Wheatley, K. (Co-Investigator)
21/07/14 → 31/10/25
Project: Other Government Departments
-
Intergroup trial for children or adolescents with B-cell NHL or B-AL: evaluation of rituximab efficacy in high risk patients (Inter-B-NHL ritux 2010)
Jackson, A. (Principal Investigator) & Wheatley, K. (Co-Investigator)
Cancer Research Uk, Institut De Cancerologie Gustave Roussy
1/11/12 → 30/06/25
Project: Research